Cathie Wood's Ark Invest Adds to Positions in Shopify, Intellia Therapeutics, and GeneDX
Cathie Wood's Ark Invest increased its holdings in Shopify, Intellia Therapeutics, and GeneDX on May 6, 2026, despite the stocks falling between 4% and 49% due to disappointing earnings and guidance. Shopify reported strong revenue and adjusted net income growth, but its stock dropped 16% after soft guidance.
Topics: Ark Invest Cathie Wood earnings report investor activity stock performance